Privium Fund Management B.V. - Q2 2024 holdings

$392 Million is the total value of Privium Fund Management B.V.'s 129 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 100.0% .

 Value Shares↓ Weighting
PUCKW ExitGOAL ACQUISITIONS CORP*w exp 99/99/999$0-73,577
-100.0%
0.00%
ExitGLOBAL GAS CORP DEL*w exp 12/21/202$0-40,637
-100.0%
0.00%
ExitEVOLV TECHNOLOGIES HLDNGS IN*w exp 03/10/202$0-131,963
-100.0%
-0.02%
NTLA ExitINTELLIA THERAPEUTICS INC$0-8,905
-100.0%
-0.06%
GPK ExitGRAPHIC PACKAGING HLDG CO$0-19,411
-100.0%
-0.15%
NVS ExitNOVARTIS AGsponsored adr$0-6,000
-100.0%
-0.16%
ExitMIRION TECHNOLOGIES INC*w exp 10/20/202$0-532,730
-100.0%
-0.32%
ExitLIBERTY GLOBAL LTD$0-87,400
-100.0%
-0.40%
PTGX ExitPROTAGONIST THERAPEUTICS INC$0-114,024
-100.0%
-0.88%
FUSN ExitFUSION PHARMACEUTICALS INC$0-251,158
-100.0%
-1.43%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2024-08-01
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPOTIFY TECHNOLOGY S A11Q2 202412.0%
SHOPIFY INC11Q2 20248.8%
OCCIDENTAL PETE CORP11Q2 202412.9%
SNOWFLAKE INC11Q2 20248.1%
CLOUDFLARE INC11Q2 20247.0%
ALPHABET INC11Q2 20245.0%
PROQR THRAPEUTICS N V11Q2 20247.7%
IONIS PHARMACEUTICALS INC11Q2 20243.8%
MERCK & CO INC11Q2 20243.9%
ARROWHEAD PHARMACEUTICALS IN11Q2 20243.4%

View Privium Fund Management B.V.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-08-01
N-PX2024-08-01
13F-HR2024-04-30
13F-HR/A2024-02-26
13F-HR2024-02-13
13F-HR2023-11-06
13F-HR/A2023-07-26
13F-HR2023-07-26
13F-HR2023-05-03
13F-HR2023-02-03

View Privium Fund Management B.V.'s complete filings history.

Export Privium Fund Management B.V.'s holdings